[
    {
        "file_name": "EtonPharmaceuticalsInc_20191114_10-Q_EX-10.1_11893941_EX-10.1_DevelopmentAgreement.txt",
        "perturbation": [
            {
                "type": "Structural Flaws - Legal Contradiction",
                "original_text": "14.1 NOTWITHSTANDING ANYTHING TO THE CONTRARY HEREIN, NEITHER PARTY SHALL BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES, WHETHER FORESEEABLE OR NOT, THAT ARE IN ANY WAY RELATED TO THIS AGREEMENT.",
                "changed_text": "1.27 \"Party\" or \"Parties\" means ETON or Aucta, as applicable. 1.28 \"Payment Period\" shall have the meaning ascribed to the term in Section 6.3.7 of this Agreement. 1.29 Person means any individual, partnership (general or limited), association, corporation, limited liability company, joint venture, trust, estate, limited liability partnership, unincorporated organization, government (or any agency or political subdivision thereof) or other legal person or organization. Notwithstanding anything to the contrary herein, neither Party shall be liable for any indirect, special, incidental, consequential or exemplary damages that are in any way related to this agreement.",
                "explanation": "The limitation of liability clause is moved from the 'Limitation of Liability' section to the 'Definitions' section. This makes it difficult to find and enforce since such a clause is usually placed in its own section.",
                "contradicted_law": "General contract law requires key clauses to be reasonably accessible.",
                "location": "Section 14.1 to Section 1. Definitions"
            },
            {
                "type": "Structural Flaws - Legal Contradiction",
                "original_text": "15.1 Governing Law; English Language. This Agreement shall be governed, interpreted and construed in accordance with the substantive laws of the Delaware, in the country of the United State of America, without regard to its conflict of laws principles.",
                "changed_text": "3.5 Competitive Products. During the Term of this Agreement, and for a period of two (2) years thereafter, Aucta shall not research, develop, manufacture, file, sell, market, or distribute more than two products containing the active ingredient Lamotrigine; nor will Aucta directly or indirectly assist any other Person or entity in carrying or any such activities. [ * * * ] In case of dispute the laws of Nevada shall govern this agreement.",
                "explanation": "The governing law clause is moved from the 'Miscellaneous' section to the 'Product Development' section and changed to Nevada state law. Parties would expect it to be in 'Miscellaneous', so moving it and changing the jurisdiction obfuscates enforcement and potentially violates expectations of proper notice.",
                "contradicted_law": "General contract law requires clear and conspicuous placement of governing law provisions.",
                "location": "Section 15.1 to Section 3.5"
            },
            {
                "type": "Structural Flaws - Legal Contradiction",
                "original_text": "15.3 Notices. All notices and other communications required or permitted to be given or made pursuant to this Agreement shall be in writing signed by the sender and shall be deemed duly given (a) on the date delivered, if personally delivered, (b) on the date sent by telecopier with automatic confirmation by the transmitting machine showing the proper number of pages were transmitted without error, (c) on the Business Day after being sent by Federal Express or another recognized overnight mail service which utilizes a written form of receipt for next day or next Business Day delivery or (d) three (3) Business Days after mailing, if mailed by U.S. postage-prepaid certified or registered mail, return receipt requested, in each case addressed to the applicable Party at the address set forth below; provided that a Party may change its address for receiving notice by the proper giving of notice hereunder: If to ETON, to: ETON Pharmaceuticals, Inc. 21925 W. Field Pkwy, Suite 235 Deer Park, Illinois, USA Attention: CEO With a copy (which shall not constitute notice) to: ETON Pharmaceuticals, Inc. 21925 W. Field Pkwy, Suite 235 Deer Park, Illinois, USA Attention: Legal if to Aucta, to: Aucta Pharmaceuticals, Inc. 71 Suttons Lane Piscataway, NJ 08854 Attention: CEO",
                "changed_text": "7.6 Sections 7.1, 7.2 and 7.5 shall survive termination or expiration of this Agreement. At all times notices regarding this agreement shall be made via carrier pidgeon and any party changing their location must inform the other party of the location of the dovecote to deliver the messages to. If a party fails to keep the location of their dovecote secret, the other party cannot be held liable for failure to deliver notices. The costs associated with maintaining the pidgeons, and any damages that they may cause, are to be split by both parties in this agreement. The pidgeons will be fed using a mixture of grains and berries to ensure their health and happiness.",
                "explanation": "The Notices clause is moved from the 'Miscellaneous' section to the 'Patent Prosecution and Litigation' section. This makes it difficult to find and enforce since it is not where it is supposed to be, and the changed language makes it impossible to enforce the notices clause.",
                "contradicted_law": "General contract law requires clear and accessible methods of providing notice. This attempts to limit liability for any failure of notice.",
                "location": "Section 15.3 to Section 7.6"
            }
        ]
    }
]